HIV gp39

HIV gp39 Full Name

Human immunodeficiency virus 2 gp39

HIV gp39 Introduction

The gp39 protein, also known as CD40 ligand (CD40L), is a 39 kDa type II transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) family. It is predominantly expressed on activated CD4+ T cells and plays an indispensable role in coordinating T-cell-dependent B-cell responses. Upon engagement with its receptor CD40 on B cells and antigen-presenting cells, gp39 initiates critical signaling cascades including JNK, p38-MAPK, ERK/MAPK, and AKT pathways, which collectively orchestrate B-cell activation, immunoglobulin class switching, and germinal center formation. The essential nature of this signaling axis is underscored by the observation that mutations in the CD40L gene cause X-linked hyper-IgM syndrome, a primary immunodeficiency characterized by defective antibody class switching and impaired humoral immunity. Beyond classical lymphoid compartments, CD40 expression on endothelial cells and dendritic cells extends the functional reach of gp39 signaling, modulating adhesion molecule expression and inflammatory responses in diverse tissue contexts.

Figure 1. gp39/CD40L Signaling Pathway and B Cell Activation.

HC-gp39, alternatively designated YKL-40 or CHI3L1, represents a secreted glycoprotein within the chitinase-like protein family (family 18) that lacks enzymatic chitinase activity. Produced by macrophages, synoviocytes, chondrocytes, and other mesenchymal cells, HC-gp39 is strongly associated with inflammatory and tissue remodeling states. Mechanistic studies have demonstrated that HC-gp39 activates ERK1/2 and AKT signaling pathways in connective tissue cells, promoting proliferation and matrix-related gene expression through PI3K and MAPK-dependent mechanisms. HC-gp39 also modulates cytokine signaling networks, interacting with inflammatory mediators such as IL-1 and TNF-α, and upregulating matrix metalloproteinase production. Although HC-gp39 is molecularly distinct from gp39/CD40L, its signaling paradigms provide a conceptual framework for understanding how gp39-family proteins may influence tissue inflammation, macrophage activation, and extracellular matrix remodeling during chronic inflammatory states.

In the context of HIV infection, gp39/CD40L signaling intersects with multiple aspects of immune dysregulation that characterize disease progression. The CD40L-CD40 axis governs T-cell help to B cells, and perturbations in this signaling pathway contribute to the hypergammaglobulinemia, B-cell dysfunction, and aberrant germinal center dynamics frequently observed in HIV-infected individuals. Studies using murine AIDS (MAIDS) models have provided direct evidence that gp39/CD40L interactions drive pathogenic immune activation and lymphoid organ remodeling; administration of anti-gp39 antibodies in these models suppresses splenomegaly and reduces disease-associated immunopathology, highlighting the functional significance of this signaling axis in retroviral contexts. The convergence of gp39-mediated signaling with inflammatory pathways elucidated through HC-gp39 research suggests a broader network in which chronic immune activation, cytokine dysregulation, and tissue remodeling in HIV infection may be modulated by gp39-family signaling components. Understanding these molecular interactions offers potential insights into therapeutic strategies targeting immune restoration and inflammation control in HIV disease.

Alternate Names for HIV gp39

Human immunodeficiency virus; HIV; Human immunodeficiency virus type 2; HIV-2; HIV-2 gp39

• 1. Recklies A., et al. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochemical Journal. 2002;365(1):119-126.
  2. Rehli M., et al. Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage Differentiation. Journal of Biological Chemistry. 2003;278(45):44058-44067.
  3. Singh S., et al. CD40 expression and function on human dermal microvascular endothelial cells: role in cutaneous inflammation. Clinical and Experimental Dermatology. 2001;26(5):434-440.